Digoxin Maintenance Dose After IV Load
For adults and pediatric patients over 10 years with normal renal function, start maintenance dosing at 2.4-3.6 mcg/kg/day (typically 0.125-0.25 mg daily), given once daily after completing the IV loading regimen. 1
Standard Maintenance Dosing for Adults
The FDA-approved maintenance dose for adults with normal renal function is:
Use the lower end (0.125 mg daily or every other day) if the patient:
Higher doses (0.375-0.50 mg daily) are rarely needed and potentially harmful 2, 3.
Renal Function-Based Dosing
The maintenance dose must be adjusted based on creatinine clearance. For a 70 kg adult with varying renal function 1:
- CrCl 100 mL/min: 238 mcg daily
- CrCl 70 mL/min: 196 mcg daily
- CrCl 50 mL/min: 168 mcg daily
- CrCl 30 mL/min: 140 mcg daily
- CrCl 10 mL/min: 112 mcg daily
Critical caveat: As renal function declines, the time to steady state increases dramatically—from 7 days at normal function to 19 days at CrCl 10 mL/min 1.
Alternative Dosing Formula
You can calculate maintenance dose using: 1
Total Maintenance Dose = Loading Dose × % Daily Loss/100
Where: % Daily Loss = 14 + (Creatinine clearance/5)
Target Serum Levels
Aim for serum digoxin concentrations <1.2 ng/mL to minimize mortality risk. Retrospective analyses demonstrate a linear relationship between mortality and digoxin levels, with significantly increased death risk at concentrations ≥1.2 ng/mL 2, 3.
Timing Considerations
- Without loading dose: Steady state is reached in 7 days with normal renal function 1
- With loading dose: Maintenance begins immediately after completing the loading regimen (typically after 12-24 hours) 1
- Doses may be increased every 2 weeks based on clinical response, serum levels, and toxicity 1
Special Populations
Elderly patients (>70 years):
- Start at 0.125 mg daily or every other day 2, 3
- Lower lean body mass and reduced renal function increase toxicity risk
Obesity/edema:
- Dose based on lean body weight, not total body weight 1
- Abnormally high total body mass relative to lean mass requires dose reduction
Common Pitfalls
- Failing to adjust for renal function: This is the most common cause of toxicity—always calculate creatinine clearance before dosing 1
- Using therapeutic drug monitoring inappropriately: Serum levels correlate poorly with efficacy but strongly with toxicity; only check levels if toxicity is suspected 4
- Drug interactions: Amiodarone, verapamil, quinidine, and spironolactone increase digoxin levels—reduce maintenance dose by 50% when adding these agents 4
- Electrolyte abnormalities: Hypokalemia and hypomagnesemia dramatically increase toxicity risk even at therapeutic levels 4, 5
Contemporary Context
Recent guidelines downgrade digoxin to a Class 2b recommendation (may be considered) for symptomatic HFrEF despite GDMT, as it reduces hospitalizations but provides no mortality benefit 2, 3. The 2022 AHA/ACC/HFSA guidelines emphasize that digoxin should only be used after optimizing guideline-directed medical therapy with ACE inhibitors/ARNIs, beta-blockers, MRAs, and SGLT2 inhibitors.